Injective Protocol has announced that it will expand its partnership with Band Protocol. As such, it will operate a validator node for BandChain.
In exchange, Band Protocol will begin participating in Equinox Staking, according to an official post. This is part of Injective Protocols testnet preparations for its upcoming mainnet deployment.
Injective is a second layer decentralized exchange created to offer derivatives and “borderless DeFi”. Users can trade any derivatives on its platform without the traditional market restrictions. The protocol is backed by Pantera Capital and Binance.
On the other hand, Band Protocol is an oracle service provider that operates cross-chain data connecting it to smart contracts. Its oracles are used to feed many decentralized applications such as DEX, prediction markets, on-chain games, and others. Backed by Sequoia Capital, it offers a platform without a single point of failure.
The partnership between the referenced protocols has a precedent with the launch of a platform for trading decentralized financial derivatives.
Developed in conjunction with Terra and Mirror Protocol, users can benefit from a decentralized platform to trade derivatives based on shares of Tesla, GameStop, Amazon, and other companies.
Band Protocols Oracle integration with Injective Protocol
The latest cooperation is a reinforcement to strengthen the relationship between the protocols. According to the post, Band Protocols oracle service will be integrated into Injective Protocols financial derivatives ecosystem.
Thus the latter will be able to expand. Injective CEO Eric Chen believes that they have remained “close friends” with Band Protocol since its inception. Chen added:
Were really excited for the Cosmos ecosystem projects to work together and secure a robust oracle and derivatives primitive alongside Band Protocol right from the start!
Band Protocol team said are “looking forward” to being able to support the expansion of Injectives ecosystem with their oracles. In addition, they believe that Equinox genesis validators will have a “diligent” execution towards the mainnet.
CEO and Co-Funder of Band Protocol Soravis Srinawakoon said the following on the cooperation:
Band Protocol has been a close collaborator of Injective from the beginning — most notably, our teams launched the world‘s first decentralized stock futures trading in collaboration with Terra and Mirror Protocol. We are proud to become a genesis validator on Injective in the lead up to their Mainnet and vice versa, have their team operate a BandChain node to further both teams’ interests.
At the time of writing, BAND is trading at $17,57 and seems to be reacting positively to the announcement with 1.8% gains in the daily chart. In the 7-day chart, BAND has 6.6% profits and 17.5% in the past month.
BAND showing gains in the daily chart. Source: BANDUSDT Tradingview